JNJ Stock Up 0.67%, Johnson & Johnson Wants to Begin Late-Stage Vaccine Trial in September
Johnson & Johnson (JNJ) stock price is rising as the company is moving forward with its vaccine trials.Johnson & Johnson (NYSE: JNJ) is set to begin late-stage COVID-19 vaccine trials in September. It will be ahead of schedule. Meanwhile, Johnson & Johnson also indicated that its phase one trial should
Read More